{"id":5873,"date":"2026-09-10T17:09:34","date_gmt":"2026-09-10T15:09:34","guid":{"rendered":"https:\/\/blog.lallianse.com\/?p=5873"},"modified":"2026-09-10T17:11:02","modified_gmt":"2026-09-10T15:11:02","slug":"2026-medicen-equity-story","status":"publish","type":"post","link":"https:\/\/blog.lallianse.com\/index.php\/en\/2026-medicen-equity-story\/","title":{"rendered":"2026 Medicen : Equity Story"},"content":{"rendered":"\n

[#EQUITYSTORY<\/a>] How do you turn an ambition into a compelling equity story?<\/strong><\/h2>\n\n\n\n

<\/p>\n\n\n\n

An \u00ab\u00a0equity story\u00a0\u00bb isn’t just about telling a nice story… it\u2019s about giving investors a clear rationale: why this solution? why you? and why now?

This is precisely the topic that Medicen Paris Region<\/a> & PariSant\u00e9 Campus<\/a> have asked Julie Rachline<\/a>, CEO LallianSe – Catalyseur d’action(s)<\/a>, to address on September 30th.

These #conversations<\/a> are part of a three-workshop series dedicated to preparing for a #lev\u00e9edefonds<\/a>, featuring Claire Verschelde<\/a> (@ICOSA | European Intellectual Property Firm<\/a>) & matthieu collin (Inserm Transfert) and Nabil Gharios<\/a> (DNA Finance<\/a>).

It is a format that brings together\u2014at just the right time\u2014the expertise #HealthTech<\/a> founders need to prepare for their next milestone.

\ud83d\udcc5 September 8 , September 30 et October 15th 2026
\ud83d\udd58 9:00 am – 10:30am
\ud83d\udccd PariSant\u00e9 Campus
\ud83d\udd17 Infos & registration https:\/\/lnkd.in\/egvECXuN<\/a>
\ud83c\udf9f\ufe0f Open to Medicen and PariSant\u00e9 Campus members only \u2013 seats are limited. <\/p>\n\n\n\n

\n\n\n\n

A look back at the first workshop<\/strong> :<\/h4>\n\n\n\n

With Claire Verschelde<\/a> (ICOSA | European Intellectual Property Firm<\/a>) & matthieu collin<\/a> (Inserm Transfert<\/a>)<\/p>\n\n\n\n